Mr. Brooks brings twenty-five years of business, legal and capital market experience advising life science companies. In 2012, he founded Medvax Technologies, Inc., to develop cancer vaccine and immunotherapies. He started his career as an investment banker with FINRA/NYSE member broker-dealers, participated in $500 million dollar of public or private offerings of biopharmaceutical and growth companies.

Mr. Clavijo, was founder & managing partner of CVP a consulting firm working with public, private, ipo, pre-ipo, & start-up companies. Prior thereto, he worked for 5 years as the Chief Accounting Officer, Treasurer, & Secretary at Soligenix (OTC: SNGX), a public clinical stage biopharmaceutical company. Mr. Clavijo worked with Deloitte & Touche & was an Officer in the U.S. Army serving for 13 years. Mr. Clavijo has raised over $1 billion.